Citation

Johnson BA, Macwilliams BA, Carey JC, Viskochil DH, D'astous JL, Stevenson DA. Pediatr. Phys. Ther. 2010; 22(4): 344-348.

Affiliation

Shriners Hospitals for Children Salt Lake City, Salt Lake City, Utah (Ms Johnson and Drs MacWilliams, Viskochil, D'Astous, and Stevenson); Department of Orthopedics (Drs MacWilliams and D'Astous) and Department of Pediatrics, Division of Medical Genetics (Drs Carey, Viskochil, and Stevenson), University of Utah, Salt Lake City, Utah.

Copyright

(Copyright © 2010, Lippincott Williams and Wilkins)

DOI

10.1097/PEP.0b013e3181f9dbc8

PMID

21068634

PMCID

PMC3235042

Abstract

PURPOSE:: Neurofibromatosis type 1 (NF1) is a genetic disorder with associated musculoskeletal abnormalities, tumors, and developmental delays. The purpose of this study was to investigate and characterize the motor proficiency of children with NF1. METHODS:: Children with NF1 were assessed using the Bruininks-Oseretsky Test (BOT 2) instrument. The NF1 group scores were compared with age and sex-matched test norms. RESULTS:: Twenty-six children participated in the study. The NF1 group had statistically significant lower scores (P < .05) for the total motor composite (Z = -1.62) and 7 of the 8 subtests. Nineteen percent (n = 5) scored in the average category, 54% (n = 14) scored in the below-average category, and 27% (n = 7) scored in the well-below-average category. CONCLUSIONS:: Children with NF1 have significantly lower motor proficiency than the BOT 2 normative scores. The results indicate the BOT 2 is useful in identifying and characterizing delays in motor proficiency for children with NF1.

Language: en